rabbit casp3 cst Search Results


99
Cell Signaling Technology Inc anti cleaved caspase 3
Anti Cleaved Caspase 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+casp3+cst/Cleaved+Caspase-3+(Asp175)+Rabbit+mAb/pmc10719266-277-51-54
Average 99 stars, based on 1 article reviews
anti cleaved caspase 3 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc 07 434 rabbit brca2 r v cst 9012 rabbit caspase 3 r v cst 9662 rabbit
07 434 Rabbit Brca2 R V Cst 9012 Rabbit Caspase 3 R V Cst 9662 Rabbit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+casp3+cst/Caspase-3+Antibody/10__1523_slash_eneuro__0272___17__2017-127-115-118
Average 99 stars, based on 1 article reviews
07 434 rabbit brca2 r v cst 9012 rabbit caspase 3 r v cst 9662 rabbit - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc cleaved caspase 3 mouse monoclonal ab
Cleaved Caspase 3 Mouse Monoclonal Ab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+casp3+cst/Caspase-3+Mouse+mAb/pmc10215342-99-102-108
Average 96 stars, based on 1 article reviews
cleaved caspase 3 mouse monoclonal ab - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc caspase 3
Caspase 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+casp3+cst/Caspase-3+Rabbit+mAb/pm37105077-38-39-41
Average 97 stars, based on 1 article reviews
caspase 3 - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc rabbit anti cleaved caspase 3
Rabbit Anti Cleaved Caspase 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+casp3+cst/Caspase-3+Rabbit+mAb/pmc12606951-74-10-13
Average 96 stars, based on 1 article reviews
rabbit anti cleaved caspase 3 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc anti caspase 3
Anti Caspase 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+casp3+cst/Cleaved+Caspase-3+(Asp175)+Rabbit+mAb/bio_rxiv__465591-97-20-23
Average 96 stars, based on 1 article reviews
anti caspase 3 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology immunostaining
Immunostaining, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+casp3+cst/p27/pmc04111700-227-11-18
Average 96 stars, based on 1 article reviews
immunostaining - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc apoptosis antibody sampler kit
Effects of punicalagin on activation of autophagy in MAB‐infected THP‐1 cells. a) Comparative analysis of peripheral blood metabolomic profiles between Mycobacterium abscessus ‐infected patients (MAB group) and healthy controls (NC group). b) CFU data at the indicated time post‐infection of MAB‐infected THP‐1 cells. c) Bacterial growth curves in 7H9 culture medium. d) Δψm was evaluated by flow cytometry analysis of JC‐1. e) Representative WB images of autophagy markers in MAB‐infected THP‐1 cells treated with punicalagin. f) Fluorescence intensity of intracellular MAB‐GFP. g) Intracellular MAB culture was treated with punicalagin followed by CFU count. h) The mRNA expression levels of genes involved in autophagy at 24 h post‐infection with MAB. i) mRNA expression levels of genes involved in autophagy 4 h post‐infection. j) THP‐1 <t>apoptosis</t> assay (4 h post‐infection). k) Quantification of apoptosis (4 h post‐infection). l) THP‐1 apoptosis assay (24 h post‐infection). m) Quantification of apoptosis (24 h post‐infection). Statistical significance is indicated as * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; ns denotes a non‐significant difference. n = 3.
Apoptosis Antibody Sampler Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+casp3+cst/Apoptosis+Antibody+Sampler+Kit/pmc12786361-335-18-22
Average 95 stars, based on 1 article reviews
apoptosis antibody sampler kit - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc anti cleaved caspase 3 alexa fluor 647
Identification of PKN1 inhibitors that decrease TRAF1 protein levels and constitutive signaling in RAJI cell lines. (a) Base line expression of TRAF1 in shCTL, shTRAF1 and shPKN1 RAJI cell lines, representative of 7 independent experiments. (b) shCTL RAJI cells were treated with the indicated inhibitor at doses ranging from 0.1 nM-10 μM for 24 h. TRAF1 expression was measured by intracellular flow cytometry after treatment. dMFI refers to the MFI for the TRAF1 stain minus the FMO (background) control. To calculate the IC 50 for PF-941222, AT7867, ipatasertib and uprosertib where TRAF1 expression was not maximally reduced, TRAF1 was assumed to reach 0 dMFI. N.D. = not determined. (c). Effect of OTSSP167 on TRAF1 levels and death of RAJI cells measured by activated <t>caspase</t> <t>3.</t> (d) Baseline expression of TRAF1 and phosphorylation of signaling intermediates pS6, pNF-κB p65 and pERK in shCTL, shPKN1 and shTRAF1 RAJI cell lines (top). shCTL RAJI cells were treated with OTSSP167 or XL-228 at the indicated concentration for 24 h. TRAF1, pS6, pNF-κB p65 and pERK were measured by flow cytometry (middle, bottom). Data are representative of 2 independent experiments
Anti Cleaved Caspase 3 Alexa Fluor 647, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+casp3+cst/MAML1+Rabbit+mAb/pmc08475556-118-4-11
Average 95 stars, based on 1 article reviews
anti cleaved caspase 3 alexa fluor 647 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc antibodies c caspase 3 cst 8172 1 200
Knockdown of DTX3L promoted HeLa and SiHa cell apoptosis. ( A , B ) Immunofluorescence analysis <t>of</t> <t>c-Caspase-3</t> expression in HeLa and SiHa cells treated with shDTX3L or shCtrl. The quantified result is shown in the right pane. ( C ) The apoptosis ability of HeLa and SiHa cells was detected by flow cytometry, and the percentage of early apoptotic (PE-A+/7-AAD−) and late apoptotic (PE-A+/7-AAD−) cells were combined for analysis. The quantified result is shown in the right panel. ( D ) Protein expression of Bcl-2, P53, Casepased-3 and c-Casepased-3 in HeLa and SiHa cells transfected with shDTX3L or shCtrl were determined by Western blot analysis. The bar chart in the right shows the ratio of Bcl-2, P53, Casepased-3 and c-Casepased-3 to Actin by densitometry. * p < 0.05; ** p < 0.01.
Antibodies C Caspase 3 Cst 8172 1 200, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+casp3+cst/Cleaved+Caspase-3+(Asp175)+Rabbit+mAb/pmc09821498-198-7-9
Average 94 stars, based on 1 article reviews
antibodies c caspase 3 cst 8172 1 200 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


Effects of punicalagin on activation of autophagy in MAB‐infected THP‐1 cells. a) Comparative analysis of peripheral blood metabolomic profiles between Mycobacterium abscessus ‐infected patients (MAB group) and healthy controls (NC group). b) CFU data at the indicated time post‐infection of MAB‐infected THP‐1 cells. c) Bacterial growth curves in 7H9 culture medium. d) Δψm was evaluated by flow cytometry analysis of JC‐1. e) Representative WB images of autophagy markers in MAB‐infected THP‐1 cells treated with punicalagin. f) Fluorescence intensity of intracellular MAB‐GFP. g) Intracellular MAB culture was treated with punicalagin followed by CFU count. h) The mRNA expression levels of genes involved in autophagy at 24 h post‐infection with MAB. i) mRNA expression levels of genes involved in autophagy 4 h post‐infection. j) THP‐1 apoptosis assay (4 h post‐infection). k) Quantification of apoptosis (4 h post‐infection). l) THP‐1 apoptosis assay (24 h post‐infection). m) Quantification of apoptosis (24 h post‐infection). Statistical significance is indicated as * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; ns denotes a non‐significant difference. n = 3.

Journal: Advanced Science

Article Title: Punicalagin Enhances Autophagy Through Sirtuin 1/FoxO3a Axis to Inhibit Intracellular Mycobacterium Abscessus Infection

doi: 10.1002/advs.202511734

Figure Lengend Snippet: Effects of punicalagin on activation of autophagy in MAB‐infected THP‐1 cells. a) Comparative analysis of peripheral blood metabolomic profiles between Mycobacterium abscessus ‐infected patients (MAB group) and healthy controls (NC group). b) CFU data at the indicated time post‐infection of MAB‐infected THP‐1 cells. c) Bacterial growth curves in 7H9 culture medium. d) Δψm was evaluated by flow cytometry analysis of JC‐1. e) Representative WB images of autophagy markers in MAB‐infected THP‐1 cells treated with punicalagin. f) Fluorescence intensity of intracellular MAB‐GFP. g) Intracellular MAB culture was treated with punicalagin followed by CFU count. h) The mRNA expression levels of genes involved in autophagy at 24 h post‐infection with MAB. i) mRNA expression levels of genes involved in autophagy 4 h post‐infection. j) THP‐1 apoptosis assay (4 h post‐infection). k) Quantification of apoptosis (4 h post‐infection). l) THP‐1 apoptosis assay (24 h post‐infection). m) Quantification of apoptosis (24 h post‐infection). Statistical significance is indicated as * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; ns denotes a non‐significant difference. n = 3.

Article Snippet: [ ] The primary antibodies used in the present study were anti‐LC3 (RRID:AB_1 079 382, Sigma, L8918), anti‐caspase‐3 (Apoptosis Antibody Sampler Kit, CST, 9915T), and anti‐β‐actin (RRID:AB_3 065 551, ABclonal, AC043), anti‐p62 (RRID:AB_2 862 742, ABclonal, A19700), anti‐STAT3 (RRID:AB_2 772 423, ABclonal, A16975), anti‐LAMP1 (RRID:AB_626 853, Santa Cruz, sc‐20011), anti‐Akt (RRID:AB_2 862 411, ABclonal, A18675), anti‐p‐Akt (RRID:AB_2 770 898, ABclonal, AP0637), anti‐mTOR (RRID:AB_2 764 355, ABclonal, A2445), anti‐p‐mTOR (RRID:AB_2 832 985, ABclonal, AP1413), Goat anti‐Rabbit IgG (H+L) Alexa Fluor 488 (RRID:AB_143 165, Thermo Fisher, A‐11008), Rabbit anti‐Mouse IgG (H+L) Alexa Fluor 555 (RRID:AB_2 535 848, Thermo Fisher, A‐21427), Goat anti‐Rabbit IgG (H+L) Alexa Fluor 555 (RRID:AB_141 784, Thermo Fisher, A‐21428), anti‐SIRT1 (RRID:AB_10 646 436, Proteintech, 13161‐1‐AP), anti‐SIRT3 (RRID:AB_2 239 240, Proteintech, 10099‐1‐AP), anti‐PI3K (RRID:AB_10 734 439, Proteintech, 20584‐1‐AP), anti‐p‐PI3K (RRID:AB_11 042 594, Proteintech, 60225‐1‐Ig), anti‐p‐STAT3 (RRID:AB_2 863 810, ABclonal, AP0705), anti‐Erk (RRID:AB_390 779, CST, 4695), anti‐p‐Erk (RRID:AB_2 315 112, CST, 4370), anti‐FoxO3a (RRID:AB_2 247 214, Proteintech, 10849‐1‐AP), anti‐ATG7 (RRID:AB_10 831 194, CST, 8558), anti‐AMPK (RRID:AB_330 331, CST, 2532), anti‐p‐AMPK (RRID:AB_331 250, CST, 2535)

Techniques: Activation Assay, Infection, Flow Cytometry, Fluorescence, Expressing, Apoptosis Assay

Schematic diagram depicts the mechanism of punicalagin‐mediated SIRT1 upregulation in counteracting MAB infection within macrophages. Punicalagin activates SIRT1, which upregulates FOXO3a, enhancing its transcriptional activity. The SIRT1/FOXO3a axis suppresses apoptosis and protects mitochondria from oxidative damage. Simultaneously, SIRT1 promotes autophagy, which is inhibited by the activation of the PI3K/Akt/mTOR pathway, enhancing autophagosome formation and phagosome‐lysosome fusion, reducing suppressed MAB‐containing phagosomes. Arrows denote activation or progression, illustrating punicalagin's role in boosting mitochondrial protection and autophagic clearance of intracellular MAB.

Journal: Advanced Science

Article Title: Punicalagin Enhances Autophagy Through Sirtuin 1/FoxO3a Axis to Inhibit Intracellular Mycobacterium Abscessus Infection

doi: 10.1002/advs.202511734

Figure Lengend Snippet: Schematic diagram depicts the mechanism of punicalagin‐mediated SIRT1 upregulation in counteracting MAB infection within macrophages. Punicalagin activates SIRT1, which upregulates FOXO3a, enhancing its transcriptional activity. The SIRT1/FOXO3a axis suppresses apoptosis and protects mitochondria from oxidative damage. Simultaneously, SIRT1 promotes autophagy, which is inhibited by the activation of the PI3K/Akt/mTOR pathway, enhancing autophagosome formation and phagosome‐lysosome fusion, reducing suppressed MAB‐containing phagosomes. Arrows denote activation or progression, illustrating punicalagin's role in boosting mitochondrial protection and autophagic clearance of intracellular MAB.

Article Snippet: [ ] The primary antibodies used in the present study were anti‐LC3 (RRID:AB_1 079 382, Sigma, L8918), anti‐caspase‐3 (Apoptosis Antibody Sampler Kit, CST, 9915T), and anti‐β‐actin (RRID:AB_3 065 551, ABclonal, AC043), anti‐p62 (RRID:AB_2 862 742, ABclonal, A19700), anti‐STAT3 (RRID:AB_2 772 423, ABclonal, A16975), anti‐LAMP1 (RRID:AB_626 853, Santa Cruz, sc‐20011), anti‐Akt (RRID:AB_2 862 411, ABclonal, A18675), anti‐p‐Akt (RRID:AB_2 770 898, ABclonal, AP0637), anti‐mTOR (RRID:AB_2 764 355, ABclonal, A2445), anti‐p‐mTOR (RRID:AB_2 832 985, ABclonal, AP1413), Goat anti‐Rabbit IgG (H+L) Alexa Fluor 488 (RRID:AB_143 165, Thermo Fisher, A‐11008), Rabbit anti‐Mouse IgG (H+L) Alexa Fluor 555 (RRID:AB_2 535 848, Thermo Fisher, A‐21427), Goat anti‐Rabbit IgG (H+L) Alexa Fluor 555 (RRID:AB_141 784, Thermo Fisher, A‐21428), anti‐SIRT1 (RRID:AB_10 646 436, Proteintech, 13161‐1‐AP), anti‐SIRT3 (RRID:AB_2 239 240, Proteintech, 10099‐1‐AP), anti‐PI3K (RRID:AB_10 734 439, Proteintech, 20584‐1‐AP), anti‐p‐PI3K (RRID:AB_11 042 594, Proteintech, 60225‐1‐Ig), anti‐p‐STAT3 (RRID:AB_2 863 810, ABclonal, AP0705), anti‐Erk (RRID:AB_390 779, CST, 4695), anti‐p‐Erk (RRID:AB_2 315 112, CST, 4370), anti‐FoxO3a (RRID:AB_2 247 214, Proteintech, 10849‐1‐AP), anti‐ATG7 (RRID:AB_10 831 194, CST, 8558), anti‐AMPK (RRID:AB_330 331, CST, 2532), anti‐p‐AMPK (RRID:AB_331 250, CST, 2535)

Techniques: Infection, Activity Assay, Activation Assay

Identification of PKN1 inhibitors that decrease TRAF1 protein levels and constitutive signaling in RAJI cell lines. (a) Base line expression of TRAF1 in shCTL, shTRAF1 and shPKN1 RAJI cell lines, representative of 7 independent experiments. (b) shCTL RAJI cells were treated with the indicated inhibitor at doses ranging from 0.1 nM-10 μM for 24 h. TRAF1 expression was measured by intracellular flow cytometry after treatment. dMFI refers to the MFI for the TRAF1 stain minus the FMO (background) control. To calculate the IC 50 for PF-941222, AT7867, ipatasertib and uprosertib where TRAF1 expression was not maximally reduced, TRAF1 was assumed to reach 0 dMFI. N.D. = not determined. (c). Effect of OTSSP167 on TRAF1 levels and death of RAJI cells measured by activated caspase 3. (d) Baseline expression of TRAF1 and phosphorylation of signaling intermediates pS6, pNF-κB p65 and pERK in shCTL, shPKN1 and shTRAF1 RAJI cell lines (top). shCTL RAJI cells were treated with OTSSP167 or XL-228 at the indicated concentration for 24 h. TRAF1, pS6, pNF-κB p65 and pERK were measured by flow cytometry (middle, bottom). Data are representative of 2 independent experiments

Journal: Oncoimmunology

Article Title: The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia

doi: 10.1080/2162402X.2021.1943234

Figure Lengend Snippet: Identification of PKN1 inhibitors that decrease TRAF1 protein levels and constitutive signaling in RAJI cell lines. (a) Base line expression of TRAF1 in shCTL, shTRAF1 and shPKN1 RAJI cell lines, representative of 7 independent experiments. (b) shCTL RAJI cells were treated with the indicated inhibitor at doses ranging from 0.1 nM-10 μM for 24 h. TRAF1 expression was measured by intracellular flow cytometry after treatment. dMFI refers to the MFI for the TRAF1 stain minus the FMO (background) control. To calculate the IC 50 for PF-941222, AT7867, ipatasertib and uprosertib where TRAF1 expression was not maximally reduced, TRAF1 was assumed to reach 0 dMFI. N.D. = not determined. (c). Effect of OTSSP167 on TRAF1 levels and death of RAJI cells measured by activated caspase 3. (d) Baseline expression of TRAF1 and phosphorylation of signaling intermediates pS6, pNF-κB p65 and pERK in shCTL, shPKN1 and shTRAF1 RAJI cell lines (top). shCTL RAJI cells were treated with OTSSP167 or XL-228 at the indicated concentration for 24 h. TRAF1, pS6, pNF-κB p65 and pERK were measured by flow cytometry (middle, bottom). Data are representative of 2 independent experiments

Article Snippet: Purified TRAF1 antibody and anti-cleaved caspase-3 Alexa Fluor 647 (clone D3E9, CST) were used prior to secondary staining with goat anti-rat PE (clone poly4054, Biolegend) for TRAF1.

Techniques: Expressing, Flow Cytometry, Staining, Concentration Assay

OTSSP167 and XL-228 decrease TRAF1 protein levels and increase cell death in primary CLL cells. (a) Representative gating strategy to identify CLL cells. TRAF1 and cleaved caspase-3 expression were measured in CLL cells by flow cytometry after treatment with DMSO control or (b) OTSSP167 or (c) XL-228 for 24 h at the indicated concentrations. In panels (B) and (C), line graphs (top) show TRAF1 dMFI and %cleaved caspase-3 + cells as mean ± SD. Histograms from one representative donor depict TRAF1 MFI (bottom left) and cleaved caspase-3 MFI (bottom right) in CLL cells after treatment with DMSO or inhibitors. TRAF1 MFI was determined by gating on Live CD5 + CD19 + CLL cells. Frequency of cleaved caspase-3 + cells was determined by gating on CD5 + CD19 + single cells. (d, e). (b, d) n = 6 CLL patient samples, 2 experiments pooled. Representative of a total of 16 donors across 8 total experiments. (c, e) n = 6 CLL patient samples, 2 experiments pooled. Representative of a total of 9 donors across 4 total experiments

Journal: Oncoimmunology

Article Title: The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia

doi: 10.1080/2162402X.2021.1943234

Figure Lengend Snippet: OTSSP167 and XL-228 decrease TRAF1 protein levels and increase cell death in primary CLL cells. (a) Representative gating strategy to identify CLL cells. TRAF1 and cleaved caspase-3 expression were measured in CLL cells by flow cytometry after treatment with DMSO control or (b) OTSSP167 or (c) XL-228 for 24 h at the indicated concentrations. In panels (B) and (C), line graphs (top) show TRAF1 dMFI and %cleaved caspase-3 + cells as mean ± SD. Histograms from one representative donor depict TRAF1 MFI (bottom left) and cleaved caspase-3 MFI (bottom right) in CLL cells after treatment with DMSO or inhibitors. TRAF1 MFI was determined by gating on Live CD5 + CD19 + CLL cells. Frequency of cleaved caspase-3 + cells was determined by gating on CD5 + CD19 + single cells. (d, e). (b, d) n = 6 CLL patient samples, 2 experiments pooled. Representative of a total of 16 donors across 8 total experiments. (c, e) n = 6 CLL patient samples, 2 experiments pooled. Representative of a total of 9 donors across 4 total experiments

Article Snippet: Purified TRAF1 antibody and anti-cleaved caspase-3 Alexa Fluor 647 (clone D3E9, CST) were used prior to secondary staining with goat anti-rat PE (clone poly4054, Biolegend) for TRAF1.

Techniques: Expressing, Flow Cytometry

Increased cell death following combined treatment with OTSSP167 and venetoclax. Primary CLL cells were cultured on OP9 stromal cells and cleaved caspase-3 expression was measured by flow cytometry following 24 h of treatment with: (a) DMSO, 10 nM OTSSP167 or 1 nM venetoclax (VEN), (b) 0.1 nM-100 nM VEN ± 10 nM OTSSP167 or (c) 1 nM-2.5 μM OTSSP167 ± 1 nM VEN. (d) Representative plots from one donor showing gating for live CLL cells and TRAF1 expression by live CLL cells. (e) Live CLL cells were gated on TRAF1 lo and TRAF1 hi cells for analysis of Bcl-2 and Mcl-1 expression. (f) TRAF1 expression on live CLL cells after treatment with the indicated dose of ventoclax (left) or OTSSP167 (right). Graphs show %cleaved caspase-3 + cells as mean±SD, n = 6 (2 independent experiments pooled). 1 CLL sample was from were new samples. Statistical analysis was performed using a non-parametric Dunn’s multiple comparisons test. *p < .05; ns, not significant. (g) Schematic showing BCR and TNFR signaling pathways in CLL, with sites of action of PKN1 inhibition and venetoclax indicated

Journal: Oncoimmunology

Article Title: The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia

doi: 10.1080/2162402X.2021.1943234

Figure Lengend Snippet: Increased cell death following combined treatment with OTSSP167 and venetoclax. Primary CLL cells were cultured on OP9 stromal cells and cleaved caspase-3 expression was measured by flow cytometry following 24 h of treatment with: (a) DMSO, 10 nM OTSSP167 or 1 nM venetoclax (VEN), (b) 0.1 nM-100 nM VEN ± 10 nM OTSSP167 or (c) 1 nM-2.5 μM OTSSP167 ± 1 nM VEN. (d) Representative plots from one donor showing gating for live CLL cells and TRAF1 expression by live CLL cells. (e) Live CLL cells were gated on TRAF1 lo and TRAF1 hi cells for analysis of Bcl-2 and Mcl-1 expression. (f) TRAF1 expression on live CLL cells after treatment with the indicated dose of ventoclax (left) or OTSSP167 (right). Graphs show %cleaved caspase-3 + cells as mean±SD, n = 6 (2 independent experiments pooled). 1 CLL sample was from were new samples. Statistical analysis was performed using a non-parametric Dunn’s multiple comparisons test. *p < .05; ns, not significant. (g) Schematic showing BCR and TNFR signaling pathways in CLL, with sites of action of PKN1 inhibition and venetoclax indicated

Article Snippet: Purified TRAF1 antibody and anti-cleaved caspase-3 Alexa Fluor 647 (clone D3E9, CST) were used prior to secondary staining with goat anti-rat PE (clone poly4054, Biolegend) for TRAF1.

Techniques: Cell Culture, Expressing, Flow Cytometry, Inhibition

Knockdown of DTX3L promoted HeLa and SiHa cell apoptosis. ( A , B ) Immunofluorescence analysis of c-Caspase-3 expression in HeLa and SiHa cells treated with shDTX3L or shCtrl. The quantified result is shown in the right pane. ( C ) The apoptosis ability of HeLa and SiHa cells was detected by flow cytometry, and the percentage of early apoptotic (PE-A+/7-AAD−) and late apoptotic (PE-A+/7-AAD−) cells were combined for analysis. The quantified result is shown in the right panel. ( D ) Protein expression of Bcl-2, P53, Casepased-3 and c-Casepased-3 in HeLa and SiHa cells transfected with shDTX3L or shCtrl were determined by Western blot analysis. The bar chart in the right shows the ratio of Bcl-2, P53, Casepased-3 and c-Casepased-3 to Actin by densitometry. * p < 0.05; ** p < 0.01.

Journal: International Journal of Molecular Sciences

Article Title: Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway

doi: 10.3390/ijms24010861

Figure Lengend Snippet: Knockdown of DTX3L promoted HeLa and SiHa cell apoptosis. ( A , B ) Immunofluorescence analysis of c-Caspase-3 expression in HeLa and SiHa cells treated with shDTX3L or shCtrl. The quantified result is shown in the right pane. ( C ) The apoptosis ability of HeLa and SiHa cells was detected by flow cytometry, and the percentage of early apoptotic (PE-A+/7-AAD−) and late apoptotic (PE-A+/7-AAD−) cells were combined for analysis. The quantified result is shown in the right panel. ( D ) Protein expression of Bcl-2, P53, Casepased-3 and c-Casepased-3 in HeLa and SiHa cells transfected with shDTX3L or shCtrl were determined by Western blot analysis. The bar chart in the right shows the ratio of Bcl-2, P53, Casepased-3 and c-Casepased-3 to Actin by densitometry. * p < 0.05; ** p < 0.01.

Article Snippet: Then, the cells were incubated with primary antibodies (c-Caspase-3, CST, #8172, 1:200) at 4 °C overnight and incubated with the appropriate secondary antibodies for 1 h at room temperature.

Techniques: Knockdown, Immunofluorescence, Expressing, Flow Cytometry, Transfection, Western Blot